NIFTPs may be reclassified not only from FVPTCs but also from follicular adenomas
Endocrine-Related Cancer · 2023
DOI: 10.1530/erc-23-0185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2023. Verfasst von Isabella Albuquerque Pinto Rebello und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Adenocarcinoma, Follicular, Thyroid Neoplasms, Adenoma. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
Few studies have focused on reclassifying follicular adenomas (FAs) as noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTPs), but none have been conducted in America or Europe. The aims of this study were to analyze the prevalence of NIFTP reclassified from follicular variant of papillary thyroid carcinomas (FVPTCs) and FAs before NIFTP was defined in the literature, the rate of NIFTP among PTC (papillary thyroid carcinomas) established in real time between 2017 and 2022, and demographic, ultrasonographic, and cytologic characteristics of NIFTPs compared with FVPTCs and FAs. This was a retrospective cohort study of tumors diagnosed as PTCs ( n = 247) and FAs ( n = 144) at a Brazilian hospital. Overall, 13.4% of PTCs and 7% of FAs were reclassified as NIFTPs. The rate of real-time diagnosed NIFTPs among PTC was 12.3%. The median tumor size was larger among NIFTPs (3.0 cm) than FVPTCs (1.1 cm; P < 0.01). A high-risk ultrasonographic pattern was rare in NIFTPs (5.6%). The cytologic classifications differed between FVPTCs and NIFTPs ( P < 0.01), and the most frequent category among NIFTPs was ‘follicular neoplasm’ (52.6%). The category ‘suspicious for malignancy’ was frequent in FVPTCs and rare (5.3%) in NIFTPs. In conclusion, FVPTCs and FAs may be reclassified as NIFTPs. The prevalence of NIFTPs reclassified from FAs was lower in our cohort than in Asian studies. The rate of NIFTPs reclassified from PTC was similar to that of NIFTPs diagnosed in real time and was aligned with rates reported in studies from America and Europe. Preoperative features could not differentiate NIFTPs from FVPTCs or FAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
- Department of Pathology, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Brazil.
ORCID-Profile: Isabella Albuquerque Pinto Rebello
Zitieren
APA
Albuquerque Pinto Rebello, I., Loures de Oliveira, V., Abbud, L. F. H., Aprígio Camargos Ferreira, T., Vidal, A. P. A., & de Fátima Dos Santos Teixeira, P. (2023). NIFTPs may be reclassified not only from FVPTCs but also from follicular adenomas. Endocrine-Related Cancer. https://doi.org/10.1530/erc-23-0185
Vancouver
Albuquerque Pinto Rebello I, Loures de Oliveira V, Abbud LFH, Aprígio Camargos Ferreira T, Vidal APA, de Fátima Dos Santos Teixeira P. NIFTPs may be reclassified not only from FVPTCs but also from follicular adenomas. Endocrine-Related Cancer. 2023. doi:10.1530/erc-23-0185
BibTeX
@article{AlbuquerquePintoRebello2023,
author = {Albuquerque Pinto Rebello, Isabella and Loures de Oliveira, Vinícius and Abbud, Luís Felipe Holzwarth and Aprígio Camargos Ferreira, Tales and Vidal, Ana Paula Aguiar and de Fátima Dos Santos Teixeira, Patrícia},
title = {NIFTPs may be reclassified not only from FVPTCs but also from follicular adenomas},
journal = {Endocrine-Related Cancer},
year = {2023},
doi = {10.1530/erc-23-0185}
}
EUVIMED